Pharma

Latest posts

Stop the UK blocking global efforts for affordable medicines


21 May 2019

This week in Geneva a resolution is being voted on which could help make drugs more affordable around the world. 

Yet we’ve discovered that the UK government is trying to undermine the resolution at this week's World Health Assembly – and is even pushing for all references to “high prices” to be taken out. This is an outrage.

It's time to get privatised medicines out of our public health system


03 December 2018

It’s good news for the NHS and patients. After years of big pharma having patent control over a medicine and hiking up its price extortionately, a drug that treats rheumatoid arthritis and Crohn's disease, adalimumab, is being replaced with much cheaper alternatives.

We need the people's prescription to fix pharma


19 October 2018

Our new report ‘The people’s prescription: Re-imagining health innovation to deliver public value’ reveals how pharmaceutical companies not only charge unaffordable prices for medicines, they are also not delivering the drugs we need. It’s a scandal of our time but there are alternatives to a system that puts profits above public need. 

Latest news

Health campaigners have called for the government to make major changes to the way medicines are researched and developed, after new analysis of the cost of leading cancer drugs to the NHS showed that £458 million was spent in 2017/18 on paying pharmaceutical companies for medicines developed with public funding.

Health campaigners have warned that the NHS drugs bill will continue to spiral unless the government takes action to tackle the exploitative behaviour of pharmaceutical companies, after NHS England statistics released today showed the NHS spent a record £20.2 billion on prescription drugs last year based on list prices.

NHS patients are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

Resources

Resource thumbail

Alternatives to the current pharmaceutical system: Activist pack to lobby your MP

December 2018

This briefing is for Global Justice Now local groups and activists to help you to lobby your MP on alternatives to the current corporate-dominated pharmaceutical system.

Resource thumbail

Taking public control of medicines

November 2018

The pharmaceutical industry makes billions in profits from charging high prices for medicines. Meanwhile, people suffer and die from treatable conditions because they can’t afford extortionate prices. This is a system driven by corporate profit that leaves vital medicines out of reach for millions of people – in the UK and around the world. It’s a system that is economically and socially unsustainable and needs urgent reform.

Resource thumbail

The people’s prescription: Re-imagining health innovation to deliver public value

October 2018

Driven by profit rather than public health, the pharmaceutical sector is incentivised to set high prices and deliver short-term returns to shareholders, rather than focus on riskier, longer-term research which leads to critically needed therapeutic advances. The high prices of medicines are causing severe patient access problems worldwide, with damaging consequences for human health and wellbeing. These are symptoms of an innovation model that is broken. This report maps the fault lines of this system and sets out principles for a new one.